miércoles, 13 de mayo de 2020

A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine

A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine

NIH/NIAID Template Banner

NIAID-Supported Research Leads to New SARS-CoV-2 Antibody Test

This scanning electron microscope image shows SARS-CoV-2 (yellow) emerging from the surface of cells (blue/pink) cultured in the lab. Credit: NIAID

With support from the NIAID Centers of Excellence for Influenza Research and Surveillance, researchers from the Icahn School of Medicine at Mount Sinai report a new lab test to identify antibodies to SARS-CoV-2, the virus that causes COVID-19. Their findings are published online today in Nature Medicine. The test has been authorized for emergency use by the U.S. Food and Drug Administration.
Read More

No hay comentarios:

Publicar un comentario